("Imperial" or the "Company")
The Company is pleased to announce that at the General Meeting of the Company held today at
As a result of the resolutions being passed, the Company’s name has today changed to
The ticker symbol will remain as IMPP.
The Company will now pursue an Investment Strategy in the medical cannabis sector. The Directors believe that the market for products which are based on, or contain, cannabis derived cannabinoids is growing strongly due to the increased awareness of the benefits of cannabinoids to various aspects of health and because of the accelerating trend towards legalising the use of medicinal cannabis products not only in the
A copy of the Circular with further details is available at:
The Directors of the Company accept responsibility for the content of this announcement.
For further information please contact:
+44 (0)7899 249990
+44 (0)20 7220 9796